- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04345302
Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.
Brief Motivational Therapy Versus Enhanced Usual Care for Alcohol Use Disorder in Primary Care in Chile, an Exploratory Randomised Trial
Harmful alcohol use is a leading cause of global disability and death. However increased detection and brief intervention capacity of more severe alcohol use disorders (AUD) has not been accompanied by increased availability of treatment services. Incorporating treatment for such disorders into primary care (PC) is of paramount importance for improving access and health outcomes. This study aims to estimate the effectiveness of a Brief Motivational Treatment (BMT) applied in primary care for treatment of these disorders.
This trial aims to test the superiority of BMT over enhanced usual care with a reasonable margin, over which the BMT could be further considered for incorporation into PC in Chile. Its pragmatic approach ultimately aims to inform policymakers about the benefit of including a brief psychosocial treatment into PC.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This exploratory trial aims to estimate the effectiveness of a BMT for AUD provided in PC. The underlying question is whether Chilean PC should incorporate this treatment among its regular programs based on its effectiveness.
To answer this question, a randomised comparison between the manualized BMT and EUC will be undertaken. The main hypothesis is a superiority one:
• Participants under BMT will perform better than EUC in the reduction of alcohol consumption.
Also, there are ancillary questions that deserve special attention. The following hypotheses will help with the explanation of the results:
- Active BMT components (i.e., the working alliance and fidelity to the MI strategies) mediate the effect.
- Participant´s AUD severity mediates the effect.
- Participants under BMT will receive a higher amount of additional care (physician consultations, social worker consultations, participation in alcoholic anonymous, and others).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nicolas A Barticevic, MD
- Phone Number: +56962225043
- Email: nabartic@uc.cl
Study Contact Backup
- Name: Diego Quevedo
- Email: daqueved@uc.cl
Study Locations
-
-
-
Santiago, Chile
- Recruiting
- CESFAM Juan Pablo II
-
Contact:
- Victoria Rodriguez
- Email: mvrodriguez1@uc.cl
-
Santiago, Chile
- Recruiting
- CESFAM Madre Teresa de Calcuta
-
Contact:
- Pedro Bustos
- Email: artrigan@hotmail.com
-
Santiago, Chile
- Recruiting
- CESFAM San Alberto Hurtado
-
Contact:
- Victoria Rodriguez
- Email: mvrodriguez1@uc.cl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of alcohol use disorder according to the DSM-V (American Psychiatric Association, 2013
- Must fulfill criteria for alcohol use disorder and criteria for harmful alcohol use during the last month, i.e., five or more heavy drinking occasions in the last month (5 or more drinks in men, 4 or more in women), or an average use of 14 or more drinks a week in men, and 7 or more in women
- Also, alcohol use should be the main problem motivating participants to seek treatment.
Exclusion Criteria:
- Clients under 20 years old
- Clients in whom alcohol use is not the main problem
- Clients who leave the area or are unable for follow-up contact
- Clients with severe mental comorbidity
- Clients with severe cognitive impairment, illiteracy, or unable to follow treatment in Spanish.
- Clients who are concurrently receiving or planning to receive other psychosocial treatment for alcohol use disorder other than usual care, i.e., formal professional treatment outside of primary care. Participation in community services and Alcoholics Anonymous is permissible.
- Clients who have previously participated in the study, or whose family members are or have been participants.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Brief motivational treatment
Participants in the intervention group will receive the Brief Motivational Treatment, which is a primary care-adaptation of the Motivational Enhancement Therapy as manualized in the Project MATCH [19]. This treatment consists of four 45-minute sessions, provided by a psychologist at weeks one, two, six, and twelve. The first three sessions, occurring during the first six weeks, are more active regarding the behavioural change, while the last session functions as closure and review of the process. If a participant asks for more support, they will be able to attend up to two extra sessions before the last one. The main adaptations are:
|
The treatment will be delivered by general psychologists with at least three years of experience in primary care. They will receive training and then will demonstrate proficiency in a simulated client session. During recruitment, therapy sessions will be recorded, and ten percent of them will be reviewed using a proficiency scale. Then, a feedback report will be issued and discussed with each therapist.
During the trial, participants will continue to receive regular medical and social care at their health centre.
These services may include prescriptions for mental health issues and alcohol (Disulfiram, anti-craving, anti-depressants, and other medications), social assistance, and the full spectrum of primary health care.
Nevertheless, they will not receive other psychosocial interventions for alcohol use disorder in the health centre.
|
|
Active Comparator: Enhanced usual care
All participants will receive an educational brochure on alcohol use disorder, with self-help materials and guides on how to get additional support. The physicians within the PC centre will also receive information on how to diagnose alcohol use disorders, prescription guides for the medications that are available for treating these disorders in the PC centre (mainly Disulfiram and any other if available), and directions on when and where to refer clients for treatment. |
During the trial, participants will continue to receive regular medical and social care at their health centre.
These services may include prescriptions for mental health issues and alcohol (Disulfiram, anti-craving, anti-depressants, and other medications), social assistance, and the full spectrum of primary health care.
Nevertheless, they will not receive other psychosocial interventions for alcohol use disorder in the health centre.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Drinks per Drinking Day (DDD)
Time Frame: Baseline and six-months follow-up
|
The change from baseline in the DDD during the last 90 days.
The DDD will be aggregated using means.
|
Baseline and six-months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the alcohol use pattern
Time Frame: Baseline and six-months follow-up
|
The number of participants with a low-risk alcohol use pattern estimated by the number of days of consumption, of abstinence, and intoxication during the last 90 days, aggregated using the proportion of participants per group.
|
Baseline and six-months follow-up
|
|
Abstinence days
Time Frame: At six-months follow-up
|
The most extended period of abstinence since enrolment.
The number of abstinence days of each participant will be aggregated using means.
|
At six-months follow-up
|
|
Change in the negative consequences of alcohol use
Time Frame: Baseline and six-months follow-up
|
The change from baseline in the negative secondary consequences of alcohol consumption will be measured using the Drinker Inventory of Consequences (DrInC-2R) questionnaire, and will be aggregated using means.
The DrInC-2R has a score range from 0 to 150, with higher scores indicating higher consequences.
|
Baseline and six-months follow-up
|
|
Change in the severity of the dependency
Time Frame: Baseline and six-months follow-up
|
The change from baseline in the severity of the alcohol use disorder using the Substance Dependence Severity Scale. Means will be used to aggregate participants' DAYS, SEV, and WORST SEV scores for alcohol. The DAYS score varies on an 8-point scale ranging from 0 (symptom did not occur) to 7 (symptom occurred every day of past 30). The SEV and WORST SEV severity variables are scored on a 6-point scale ranging from 0 (absent) to 5 (extreme), with a score of '2' indicating that the diagnostic criterion has been met. Lower scales scores represent less severe dependence, and higher scale scores reflect more severe dependence. |
Baseline and six-months follow-up
|
|
Change in the motivation for change
Time Frame: Baseline and six-months follow-up
|
The change from baseline in the motivational stage measured with the Stages of Change Readiness and Treatment Eagerness Scale-Drug (SOCRATES).
The proportion of participants that improve their motivational stage will be used to aggregate the measurement in each group.
The SOCRATES scores range within three dimensions: Recognition (7 - 35), Ambivalence (4 - 20), and Taking Steps (8 - 40), with higher scores indicating higher involvement in the dimension.
|
Baseline and six-months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicolas Barticevic, MD, Adjunct Professor School of Medicine Pontificia Universidad Catolica de Chile
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FONDECYT 11190874
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
University of Notre DameNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use | Opioid Use Disorder | Alcohol Use Disorder | Opioid UseUnited States
Clinical Trials on Brief motivational treatment
-
Hospital Clinic of BarcelonaMinistry of Health, SpainCompletedSubstance-Related DisordersSpain
-
Centre for Addiction and Mental HealthTerminated
-
Connecticut Children's Medical CenterCommunity Health NetworkCompleted
-
San Diego State UniversityUnited States Naval Medical Center, San DiegoCompletedAlcohol DependencyUnited States
-
Centers for Disease Control and PreventionWithdrawnAccidents, Traffic
-
University of California, San DiegoUniversity of Southern California; Lundquist Institute for Biomedical Innovation... and other collaboratorsCompletedHIV Seronegativity | Patient AdherenceUnited States
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | HIV | Drug UseUnited States
-
Stony Brook UniversityRecruiting
-
University Hospital, GrenobleRecruiting
-
University of California, DavisUniversity of Michigan; Robert Wood Johnson Foundation; Sacramento Police Department and other collaboratorsCompleted